Vimarsana
Biggest News Aggregation in the World

Page 2 - Advance Purchase Commitment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Advance Purchase Commitment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Advance Purchase Commitment Today - Breaking & Trending Today

Unicef inks deal to supply of 220mn Covid vax doses to Africa - Vimarsana News

Unicef inks deal to supply of 220mn Covid vax doses to Africa

Unicef inks deal to supply of 220mn Covid vax doses to Africa ​ By IANS | ​ 7 Views   Unicef inks deal to supply of 220mn Covid vax doses to Africa. Image Source: IANS News United Nations, July 9 : The Unicef has announced the signing of an agreement with Janssen Pharmaceutica NV to supply 220 million doses of the Johnson & Johnson single-dose vaccine against Covid-19 for all 55 member states of the African Union (AU) by the end of 2022. Some 35 million doses are to be delivered by the end of 2021, Xinhua news agency quoted the Unicef as saying in a statement on Thursday. The agreement...

UNICEF inks deal to supply of 220 million COVID vaccine doses to Africa - Vimarsana News

UNICEF inks deal to supply of 220 million COVID vaccine doses to Africa

  The United Nations Children’s Emergency Fund (Unicef) has announced the signing of an agreement with Janssen Pharmaceutica NV to supply 220 million doses of the Johnson & Johnson single-dose vaccine against Covid-19 for all 55 member states of the African Union (AU) by the end of 2022. Some 35 million doses are to be delivered by the end of 2021, Xinhua news agency quoted the Unicef as saying in a statement on Thursday. The agreement between Unicef and Janssen will help implement the Advance Purchase Commitment signed between the African Vaccine Acquisition Trust (AVAT) and Janssen in...

African Union member states accelerates online pre-orders as Africa Medical Supplies Platform (AMSP) adds 300 million Sputnik V doses to its COVID-19 vaccine portfolio - Vimarsana News

African Union member states accelerates online pre-orders as Africa Medical Supplies Platform (AMSP) adds 300 million Sputnik V doses to its COVID-19 vaccine portfolio

Content provided by Last updated: 19/02 - 11:20 The Africa Vaccine Acquisition TaskTeam [AVATT], set up by the African Union to acquire additional vaccine doses so that Africa can attain a target immunization of 60%, is pleased to advise that it has received an offer of 300 million Sputnik V vaccines from the Russian Federation. This includes a financing package for any member states wishing to secure this vaccine. Meanwhile, AVATT advises that the 270 million doses previously secured from AstraZeneca, Pfizer and Johnson & Jo...

APO Group - Africa Newsroom / Press release | African Union member states accelerates online pre-orders as Africa Medical Supplies Platform (AMSP) adds 300 million Sputnik V doses to its COVID-19 vaccine portfolio - Vimarsana News

APO Group - Africa Newsroom / Press release | African Union member states accelerates online pre-orders as Africa Medical Supplies Platform (AMSP) adds 300 million Sputnik V doses to its COVID-19 vaccine portfolio

Ambassade d'Allemagne - Libreville Ambassade d'Allemagne au Togo Ambassade d'Italie à Alger en Algérie Ambassade de Côte d´Ivoire en Espagne Ambassade de Djibouti à Washington, D.C., États-Unis Ambassade de France à Abidjan, Côte d'Ivoire Ambassade de France à Asmara, Erythrée Ambassade de France à Bissau, Guinée-Bissau Ambassade de France à Brazzaville, Congo Ambassade de France à Cotonou Ambassade de France à Dar es Salaam, Tanzanie Ambassade de France à Djibouti Ambassade de France à Khartoum, Soudan Ambassade de France à Lomé, Togo Ambassade de France à Madagascar Amba...

Gavi to make 500,000 doses of Ebola vaccine available for outbreaks - Vimarsana News

Gavi to make 500,000 doses of Ebola vaccine available for outbreaks

This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website. Manage your cookiesI agree Cookie Settings Cookie Settings This website uses cookies to improve your experience whil...